USTEKINUMAB

Clinical Indication

For refractory Crohn’s disease in pre-pubescent children (aged < 6 years old)

Comments

In line with NHSE Clinical Commissioning Policy.

Date of classification

May 2025

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.